Arrowhead Pharma (ARWR) PT Raised to $123 at B.Riley
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.34 -0.17%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
B.Riley analyst Chad L. Mabry raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $123.00 (from $101.00) while maintaining a Buy rating.
You May Also Be Interested In
- Jefferies Downgrades Xior Student Housing NV (XIOR:BB) to Hold
- Soitec (SOI:FP) (SLOIF) PT Raised to EUR98 at Jefferies
- Trimegah Bangun Persada Tbk PT (NCKL:IJ) PT Lowered to IDR1,750 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
